'Modular' Leukemia Drug Shows Promise In Early Testing

A new type of engineered drug candidate has shown promise in treating chronic lymphocytic leukemia in both test tube and early animal tests, a new study shows.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news102337140.html">'Modular' Leukemia Drug Shows Promise In Early Testing</a></p> <p>A new type of engineered drug candidate has shown promise in treating chronic lymphocytic leukemia in both test tube and early animal tests, a new study shows. </p>